Costs of infertility treatment: results from an 18-month prospective cohort study

Objective: To examine resource use (costs) by women presenting for infertility evaluation and treatment over 18 months, regardless of treatment pursued. Design: Prospective cohort study in which women were followed for 18 months. Setting: Eight infertility practices. Patient(s): Three hundred ninety-eight women recruited from infertility practices. Intervention(s): Women completed interviews and questionnaires at baseline and after 4, 10, and 18 months of follow-up. Medical records were abstracted after 18 months to obtain details of services used. Main Outcome Measure(s): Per-person and per-successful-outcome costs. Result(s): Treatment groups were defined as highest intensity treatment use. Twenty percent of women did not pursue cycle-based treatment; approximately half pursued IVF. Median per-person costs ranged from $1,182 for medications only to $24,373 and $38,015 for IVF and IVF-donor egg groups, respectively. Estimates of costs of successful outcomes (delivery or ongoing pregnancy by 18 months) were higher-$61,377 for IVF, for example-reflecting treatment success rates. Within the time frame of the study, costs were not significantly different for women whose outcomes were successful and women whose outcomes were not. Conclusion(s): Although individual patient costs vary, these cost estimates developed from actual patient treatment experiences may provide patients with realistic estimates to consider when initiating infertility treatment. (Fertil Steril (R) 2011; 95: 915-21. (C) 2011 by American Society for Reproductive Medicine.)